James Green

Translating the complexity of a world in motion into the intelligence you need.

JG
Editor
James Green

About This Column

James Green is a writer and strategist dedicated to finding the "signal in the noise" of modern progress. Building on a career spent deconstructing the high-stakes world of biotech and medical innovation, James now applies his forensic curiosity to the broader forces of change. He specializes in translating complex technological, market, and social shifts into clear, actionable insights. Whether he is analyzing a disruptive new industry, a shift in global investment, or the future of infrastructure, James provides the critical context needed to understand how today’s breakthroughs will reshape our world tomorrow.

Displaying items 501-520 of 525 in total

Closing the OT Security Gap: Quest & Crytica Target Sub-Minute Breaches

Read full article
Closing the OT Security Gap: Quest & Crytica Target Sub-Minute Breaches

The Everything Wallet: Kickstarter Darling or Over-Engineered Gadget?

Read full article
The Everything Wallet: Kickstarter Darling or Over-Engineered Gadget?

New Far-UVC Light Tech Neutralizes H5N1, Bolstering Food Security

Read full article
New Far-UVC Light Tech Neutralizes H5N1, Bolstering Food Security

CytomX Spotlight: Can Masked Biologics Unmask Investor Value?

Read full article
CytomX Spotlight: Can Masked Biologics Unmask Investor Value?

Teva Enters Europe's $1.2B Bone Drug Market with Biosimilar Approvals

Read full article
Teva Enters Europe's $1.2B Bone Drug Market with Biosimilar Approvals

MSIG's Cyber Gambit: New Chief to Tackle Volatile Digital Risk Market

Read full article
MSIG's Cyber Gambit: New Chief to Tackle Volatile Digital Risk Market

Tempest Therapeutics Secures Lifeline Funding Amid Strategic Pivot

Read full article
Tempest Therapeutics Secures Lifeline Funding Amid Strategic Pivot

The Seaweed Solution: How Alginate is Driving Medical Innovation

Read full article
The Seaweed Solution: How Alginate is Driving Medical Innovation

Hexaware's German Debut: A New Blueprint for IT Sourcing Value

Read full article
Hexaware's German Debut: A New Blueprint for IT Sourcing Value

AI Scribes Slash Admin Time, Offering a Lifeline for Mental Health Care

Read full article
AI Scribes Slash Admin Time, Offering a Lifeline for Mental Health Care

USVI Wields $24B Rebuild to Pressure Caribbean 'Golden Passport' Nations

Read full article
BriefGlance

The Sophistication Shift: AI Arms Race Redefines Digital Fraud

Read full article
The Sophistication Shift: AI Arms Race Redefines Digital Fraud

Rocket Lab & JAXA Pact: A Strategic Lift for Small Satellite Market

Read full article
Rocket Lab & JAXA Pact: A Strategic Lift for Small Satellite Market

Beyond the Blueprint: How Integrated Design Drives Business Growth

Read full article
Beyond the Blueprint: How Integrated Design Drives Business Growth

Canada's 'Painted Forest' Sets New Standard for Carbon Credits

Read full article
Canada's 'Painted Forest' Sets New Standard for Carbon Credits

Europe's Car Wash Boom: How Data is Fueling a $4.3B Industry

Read full article
Europe's Car Wash Boom: How Data is Fueling a $4.3B Industry

Manitoba's $2M Bet on Virtual Care for Francophone Patients

Read full article
BriefGlance

AI Nears FDA Submission After 99.5% Heart Failure Detection at Mayo Clinic

Read full article
AI Nears FDA Submission After 99.5% Heart Failure Detection at Mayo Clinic

Beyond Chatbots: GenAI Now Negotiates Deals and Runs Mines

Read full article
Beyond Chatbots: GenAI Now Negotiates Deals and Runs Mines

Biodexa Launches EU Trial for First Pill to Prevent Genetic Cancer

Read full article
Biodexa Launches EU Trial for First Pill to Prevent Genetic Cancer
UCID: 64